SCHEMBL23589607

SCHEMBL23589607

CC(C)(C)c1ccc(Nc2cc(C(C)(C)C)cc(N(c3ccc(C(C)(C)C)cc3)c3ccc(C(C)(C)C)cc3)c2Cl)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1C3 P42330 2/20 0.36
▸ AKR1C2 P52895 2/20 0.36
▸ RAB9A P51151 3/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ SLC2A1 P11166 1/20 0.34
▸ CNR1 P21554 2/20 0.33
▸ POLB P06746 1/20 0.33
▸ MAPT P10636 4/20 0.32
▸ MEN1 O00255 3/20 0.32
▸ KMT2A Q03164 3/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ HPGD P15428 2/20 0.32
▸ MAPK1 P28482 2/20 0.32
▸ HTT P42858 2/20 0.32
▸ NPSR1 Q6W5P4 2/20 0.32
▸ TDP1 Q9NUW8 2/20 0.32
▸ L3MBTL1 Q9Y468 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ THRB P10828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29292642 0.89 CNR1 (0.38) AKR1C3AKR1C2RAB9ANPC1SMN1; SMN2
SCHEMBL23589543 0.89 AKR1C3 (0.33) AKR1C3AKR1C2RAB9ANPC1SMN1; SMN2
SCHEMBL29292631 0.89 SLC2A1 (0.36) AKR1C3AKR1C2RAB9ANPC1SMN1; SMN2
SCHEMBL27290069 0.88 TSHR (0.33) AKR1C3AKR1C2RAB9ANPC1SLC2A1
SCHEMBL29293713 0.88 AKR1C3 (0.34) AKR1C3AKR1C2RAB9ANPC1SMN1; SMN2
SCHEMBL29292671 0.86 CNR1 (0.32) AKR1C3AKR1C2CNR1
SCHEMBL27290159 0.84 CNR1 (0.39) AKR1C3AKR1C2RAB9ANPC1SMN1; SMN2
SCHEMBL25128679 0.84 CYP26A1 (0.34) MEN1KMT2AALDH1A1MAPK1
SCHEMBL23589544 0.83 AKR1C3 (0.44) AKR1C3AKR1C2RAB9ANPC1SMN1; SMN2
SCHEMBL25772649 0.83 POLB (0.37) AKR1C2RAB9ANPC1SMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240209006-A1 ORGANIC COMPOUND, LIGHT-EMITTING ELEMENT, AND DISPLAY PANEL SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2024-06-27 — — US disclosed
WO-2021129724-A1 ARYLAMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE 陕西莱特光电材料股份有限公司 2021-07-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240209006-A1 ORGANIC COMPOUND, LIGHT-EMITTING ELEMENT, AND DISPLAY PANEL NR2E3, NR2C2, NR4A2 AKR1C3 508/4885AKR1C2 1446/4885RAB9A 3889/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback